It's Still Early To Buy Snap - Cramer's Lightning Round (11/20/18)

by: SA Editor Mohit Manghnani

Five Below is a buy at $103.

3D Systems had a bad quarter. Stay away.

The biosimilar drug market is crowded.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, November 20.

Bullish Calls

Five Below (NASDAQ:FIVE): It has fallen down one way to $103 and is oversold. Cramer likes the stock.

Splunk (NASDAQ:SPLK): This is another stock that is in free fall. It's a good company, but in this bear market everything is going down and Cramer does not know when it will bottom.

Bearish Calls

Crown Castle (NYSE:CCI): The best stock in the 5G space is Qualcomm (NASDAQ:QCOM) and it yields the same as CCI. Cramer has been recommending but 5G is still two years away.

Square (NYSE:SQ): It's up 78% and people can't stop selling with huge gains like these. It's a good company nonetheless.

3D Systems (NYSE:DDD): Their last quarter was not good. Don't buy.

Dana (NYSE:DAN): "That thing is down big. It's down 50%. I would actually like to own one of these tech stocks that's not doing badly that people think are doing badly because we're in a bear market in tech."

Alibaba Group (NYSE:BABA): It's still not time to recommend Chinese stocks.

Coherus Biosciences (NASDAQ:CHRS): The biosimilar market is crowded. Don't buy.

Snap (NYSE:SNAP): It's still early to buy Snap.


Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up